Researchers from Charité – Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medications.
The researchers used computer simulations to develop new opioids that will only work at sites affected by injury or inflammation. These drugs can prevent the occurrence of brain- and gut-related side effects typically associated with conventional opioids and have been shown to be successful in preclinical studies. Results from this research have been published in Pain* and Scientific Reports**.
Opioids are a class of drugs with powerful pain-relieving properties. They are mainly used to treat the pain associated with tissue damage and inflammation, such as that caused by surgery or cancer. Common side effects associated with their use include drowsiness, nausea, constipation, dependency and, in some cases, respiratory arrest. The research team, which is led by Prof. Dr. Christoph Stein of the Department of Anesthesiology and Surgical Intensive Care Medicine on Campus Benjamin Franklin, are hoping to develop new types of pain medications which will work without producing dangerous side effects. Collaborating with PD Dr. Marcus Weber of the Zuse Institute Berlin, the researchers used computer simulations to develop two new opioids. In both cases, the researchers used fentanyl as the starting molecule.
The researchers hypothesized that tissues which are damaged or inflamed show stronger interaction between ‘opioid agonists’ – the substances that elicit the pain-relieving effect – and the opioid receptors they bind to. Their computer simulations suggested that this is due to an increased concentration of protons in inflamed tissues, which leads to lower pH values than in healthy tissues, resulting in acidic conditions. Opioid molecules need to undergo protonation before they can bind to and activate opioid receptors. The researchers used this knowledge to design two drugs that would only exist in their protonated state in the presence of inflammation. This restricts opioid receptor activation to sites of tissue damage or inflammation, rather than receptors in the brain or gut.
“Our innovative design method provides a robust basis for a new generation of pain medications,” reports Prof. Stein. He adds: “These drugs could help us both to avoid the dangerous side effects of conventional opioids and to reduce complications. They would also help us stem the opioid crisis, a problem that is particularly evident in the United States.”
The researchers hope to further develop these newly-designed drugs in order to make them available to patients. They also plan to enhance their understanding of the molecular processes underlying the complex interactions seen in inflamed tissues, in the hope that they may be able to support opioid optimization through the insights they gain. Ideally, their insights will also be beneficial for other drugs, such as those used to treat high blood pressure.
The Latest on: Pain medications
via Google News
The Latest on: Pain medications
- Louisiana Doctor Develops Pain Cream that Helps Eliminate Pain Medication on December 20, 2018 at 7:35 am
A year ago, Dr. Craig Morton, physical medicine and rehabilitation specialist with Center for Orthopaedics in Lake Charles, LA, introduced a pain relief cream called Aculeve, and now he is rolling out ... […]
- Cordant Announces Expanded Mental Health Monitoring Capabilities to Increase Medication Adherence for Chronic Conditions on December 20, 2018 at 6:32 am
DENVER, Dec. 20, 2018 /PRNewswire/ -- Cordant Health Solutions™, a leading provider of innovative tools for monitoring and managing behavioral health and chronic pain patients through its unique ... […]
- Opioids Flop for Chronic Pain; Probiotics for Bipolar; Binge Eating & Food Insecurity on December 19, 2018 at 12:33 pm
Opioids offer little relief of chronic pain not due to cancer ... (ScienceDaily) The FDA will review Intra-Cellular Therapies' investigational schizophrenia treatment lumateperone -- a dual 5HT2A rece... […]
- Opioids offer little benefit in long-term chronic pain treatment, study says on December 19, 2018 at 11:34 am
New research suggests that prescription opioids may offer little more benefit than placebos for patients who are being treated for long-term, non-cancer-related pain. The findings, published in the Jo... […]
- Nerve Stimulation Devices for Migraine Treatment on December 19, 2018 at 11:21 am
but it can be used alongside prescribed drug treatment to reduce migraine episodes or pain intensity,” says Dr. Robbins. Nerve stimulation isn’t one single approach. In fact, there are several approac... […]
- Powerful Democrat wants Pfizer to explain price hikes for Lyrica, its nerve pain drug on December 19, 2018 at 1:40 am
WASHINGTON — A powerful Senate Democrat is asking Pfizer to explain why it hiked the price of its nerve pain drug, Lyrica ... in November to increase the price of 41 yet-to-be-disclosed drugs. He also ... […]
- US: Fears Of Prescribing Hurt Chronic Pain Patients, Says HRW on December 18, 2018 at 9:16 pm
Federal and state government efforts to reduce prescription opioids are inadvertently harming chronic pain patients in the United States, Human Rights Watch said in a new report. Many patients are inv... […]
- Punishing Patients Won't Reduce Opioid Deaths: A New Medicare Prescription Rule Will Aggravate Undertreatment of Pain on December 18, 2018 at 8:01 pm
A patient with metastatic prostate cancer tried to kill himself after he could not get the medication he was prescribed for bone pain because a suspicious pharmacist called his insurer ... […]
- Study: Opioids offer little chronic pain benefits and wane over time on December 18, 2018 at 6:46 pm
... ability of medication-assisted treatment drugs like methadone and buprenorphine to save the lives of people who've overdosed on opioids, they continue to be underutilized. (CNN) - For adults with ... […]
via Bing News